Baxter International Faces Class Action Over Concealed Defects in Novum Pump Devices
- Baxter International faces class action lawsuits for allegedly concealing defects in its Novum Large Volume Pump, impacting patient safety.
- The company is accused of knowing about device malfunctions that caused injuries but failing to address them adequately.
- Investors are encouraged to join the lawsuits, which do not require out-of-pocket costs, as Baxter’s reputation is at stake.
Baxter International Faces Allegations of Concealed Device Defects in Class Action Lawsuit
Baxter International Inc. is currently embroiled in a significant legal challenge as multiple law firms announce class action lawsuits on behalf of investors who claim to have suffered substantial losses related to the company. The lawsuits center around allegations of securities fraud connected to Baxter's Novum Large Volume Pump (LVP), a medical device designed for fluid delivery. The allegations assert that from February 23, 2022, to July 30, 2025, Baxter failed to disclose critical information regarding systemic defects in the Novum LVP, which reportedly led to severe malfunctions such as underinfusion, overinfusion, and complete non-delivery of fluids. These issues pose grave risks to patient safety, undermining the trust that healthcare providers place in Baxter's products.
The complaints allege that Baxter was aware of multiple incidents of malfunctioning devices resulting in injuries and even fatalities but did not adequately address these issues. Instead, the company is accused of issuing insufficient customer alerts while persistent design flaws remained unrectified. This negligence not only jeopardizes patient safety but also jeopardizes the company's operational stability, as existing Novum LVPs may be removed from service, halting new sales and damaging Baxter's reputation in the healthcare industry. The failure to disclose such critical information may have led to misleading assertions about the company’s business prospects, further complicating the situation for investors.
As the legal landscape evolves, investors who have incurred losses are encouraged to consider their options for participating in the class action lawsuits. The lead plaintiff deadline is set for December 15, 2025, providing potential participants with time to evaluate their circumstances and seek legal counsel. Importantly, these lawsuits are structured so that participants do not incur out-of-pocket costs, allowing them to pursue potential recovery without financial risk. The outcome of these lawsuits could have significant implications for Baxter International's reputation and its future conduct regarding product safety disclosures.
In addition to the class action lawsuits, law firms like Levi & Korsinsky LLP and Rosen Law Firm emphasize the importance of engaging experienced legal counsel to navigate the complexities of securities litigation. They highlight their track records in securing settlements for investors, underscoring the need for those affected by Baxter's alleged misconduct to act promptly. As the situation develops, Baxter’s response to these allegations will be pivotal in shaping the company’s future and restoring trust among its stakeholders.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

